E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/1/2011 in the Prospect News High Yield Daily.

Moody's: MedImpact unchanged

Moody's Investors Service said there is no change to MedImpact Holding, Inc.'s B3 corporate family rating and Caa2 senior secured notes following the recent announcement of a potential merger between Harvard Pilgrim Healthcare, a significant customer of MedImpact, and Tufts Health Plan.

The outlook remains stable.

The agency said it is too early to determine the impact of a merger, should it occur.

Moody's said it understands that Tufts currently uses CVS/Caremark for its pharmacy benefits management services.

Because Harvard Pilgrim is a key customer of MedImpact, the agency said it will continue to monitor the situation closely. A termination of this contract could be material to the company's credit profile, Moody's said.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.